Barry Buzogany

Barry Buzogany is the current director at T3D Therapeutics. Barry has also served on the board of directors for the Marine Bio-Technologies Center of Innovation (MBCOI) from February 2014 to April 2018. Additionally, they were a mentor for the Venture Mentoring Service through the Council for Entrepreneurial Development from March 2011 to June 2014. Barry has also served as an advisory board member for OpiAid LLC and GeneCoda.

Buzogany has dedicated their career to helping others commercialize new scientific discoveries. Through their work with the MBCOI, they facilitated collaboration among universities, industry, and funding organizations to help bring new marine technologies to market. As a mentor with the CED, they assisted medical device, nanotechnology, and hybrid vehicle companies in developing their products and bringing them to market. In their role as an advisory board member, they have provided guidance to companies developing novel products in the medical and biotechnology fields.

Buzogany’s experience and expertise have helped countless companies bring innovative new products to market. Barry is a skilled facilitator and advisor who has a passion for helping others succeed.

Barry Buzogany has a Masters degree in International Relations from Univ. of Southern California (United Kingdom Graduate Program). Barry also has a Juris doctorate in Law from University of Akron School of Law. In addition, they have certification from Achieve Global (formerly Zenger-Miller) in Front Line Leadership Program for training new and middle level managers and supervisors, i.e., a "train the trainers" certification program.